News

PCI Pharma Services ("PCI" or the "Company"), a world-leading global contract development and manufacturing organization ...
The new investment will support both organic and inorganic expansion, including growth in sterile fill-finish injectables, ...
PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and ...
More recently, PCI acquired a 100% stake in Ajinomoto’s fill-finish contracting arm Ajinomoto Althea. The deal, for which ...
A Philadelphia-based pharmaceutical services company has just received a massive investment from two major private equity firms, reportedly catapulting its valuation to $10 billion.
PCI Pharma Services, a Philadelphia-based biotherapy-focused contract development and manufacturing organization, has secured an investment co-led by Bain Capital and existing backer Kohlberg.
Bain Capital and Kohlberg have completed a strategic investment in PCI Pharma Services, according to a news release.
Weekly companies-for-sale update, featuring two newly announced deals in fire safety and drug development; KKR announces ...
Mubadala Investment Company (Mubadala), announced the official commencement of the Al Maryah Waterfront enhancement project, ...
Mubadala Investment Company, the Abu Dhabi-based sovereign wealth fund managing a global portfolio, is making a significant reinvestment in PCI Pharma Services (PCI).
PCI Pharma Services has secured a new round of strategic investment, with Bain Capital joining existing lead investor Kohlberg and reinvestment partner Mubadala Investment Company to support ...